Microbot Price To Sales Ratio from 2010 to 2025
| MBOT Stock | USD 1.53 0.01 0.66% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 383.31 | Current Value 302.36 | Quarterly Volatility 175.15419693 |
Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 90.6 K, Interest Expense of 158.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 302, Dividend Yield of 58.41 or PTB Ratio of 5.21. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.
Microbot | Price To Sales Ratio |
Latest Microbot Medical's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Microbot Medical over the last few years. Price to Sales Ratio is figured by comparing Microbot Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Microbot Medical sales, a figure that is much harder to manipulate than other Microbot Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Microbot Medical's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbot Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.00 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Microbot Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 299.20 | |
| Geometric Mean | 197.73 | |
| Coefficient Of Variation | 58.54 | |
| Mean Deviation | 153.45 | |
| Median | 425.90 | |
| Standard Deviation | 175.15 | |
| Sample Variance | 30,679 | |
| Range | 416 | |
| R-Value | 0.71 | |
| Mean Square Error | 16,093 | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 26.28 | |
| Total Sum of Squares | 460,185 |
Microbot Price To Sales Ratio History
About Microbot Medical Financial Statements
Microbot Medical shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Microbot Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Microbot Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Microbot Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 383.31 | 302.36 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.